Coronavirus company news summary – BD announces approval for immune assessment assay – Oceanit readies rapid COVID-19 test developed in Hawaii

19 October 2020 (Last Updated October 19th, 2020 09:39)

BD has announced that its BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes has received the CE mark and distribution approvals to assess immunity among Covid-19 patients in Europe. The product is expected to help clinicians better understand immune responses to the Covid-19 disease.

Researchers from the Indian Institute of Science Education and Research in Pune, India have developed a new test to measure the loss of smell quickly and accurately in Covid-19 patients. A specially developed olfactory action meter was used by the researchers to identify the virus in individuals having no additional symptoms such as fever or fatigue. The test identified olfactory deficits in 82% of the 34 asymptomatic patients.

Softlab9 Technologies, a software solutions company, announced that it has procured 1,000 rapid antigen Covid-19 testing kits from Zhejiang Orient Gene Biotech, a Chinese biotech company. The RA test kits can detect the virus from saliva samples within 15 minutes. The kits are approved in the US, Australia, and Europe, but not yet in Canada where the company is based.

Oceanit Laboratories, a biotech company, is planning to file an application for approval with the US Food and Drug Administration (FDA) for a Covid-19 test developed in Hawaii. The test provides results within three to ten minutes and is expected to cost between $5 to $20. The company expects to receive approval within the next few weeks although availability of the test could take a few months.